您的位置: 专家智库 > >

国家教育部博士点基金(20100171110077)

作品数:3 被引量:18H指数:1
相关作者:周民稳张秀兰葛坚王伟黄丹平更多>>
相关机构:中山大学更多>>
发文基金:国家教育部博士点基金国家自然科学基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 3篇中文期刊文章

领域

  • 3篇医药卫生

主题

  • 2篇GLAUCO...
  • 1篇引流
  • 1篇引流管
  • 1篇植入
  • 1篇植入术
  • 1篇皮瓣
  • 1篇青光
  • 1篇青光眼
  • 1篇外科
  • 1篇外科皮瓣
  • 1篇巩膜
  • 1篇覆盖物
  • 1篇OIL
  • 1篇TRPC6
  • 1篇UNDERL...
  • 1篇ACIDS
  • 1篇CANONI...
  • 1篇FATTY
  • 1篇SUPPLE...
  • 1篇TRANSI...

机构

  • 1篇中山大学

作者

  • 1篇黄丹平
  • 1篇王伟
  • 1篇葛坚
  • 1篇张秀兰
  • 1篇周民稳

传媒

  • 2篇Intern...
  • 1篇中华眼科杂志

年份

  • 1篇2013
  • 1篇2012
  • 1篇2011
3 条 记 录,以下是 1-3
排序方式:
TRPC6:an underlying target for human glaucoma
2012年
·Glaucoma is one of the leading causes of visual impairment and blindness worldwide. Of known risk factors for glaucoma, an increased in intraocular pressure is most highly correlated with glaucomatous damage. Irrespective of the cause, apoptosis of the retinal ganglion cells is the eventual outcome. It is widely accepted that glaucoma is a neurodegenerative disease that is strongly correlated with central nervous system disorders, such as Alzheimer's disease. These two disorders also share some similarities in pathogenic mechanisms. Recent studies suggest that the transient receptor potential canonical 6 channel could work together with brain-derived neurotrophic factor to promote neuron survival in brain and retina. In this study, we propose that transient receptor potential canonical 6 may contribute to the pathogenesis of human glaucoma and become a potential therapeutic target.
Qian FanWen-Bin Huangand Xiu-Lan Zhang
关键词:GLAUCOMATRANSIENTCANONICALNEUROPROTECTION
不同材料的引流管覆盖物在房水引流阀植入术中的应用研究被引量:17
2013年
目的探讨以异体和自体巩膜及生物硬脑膜材料作为引流管覆盖物在房水引流阀植入术中治疗难治性青光眼的疗效及其并发症。方法回顾性系列病例研究。对2009年1月至2011年6月,行FP-7Ahmed阀植入术的35例(35只眼)难治性青光眼患者的临床资料进行回顾性分析。术后各组间各个随访时间点的平均眼压比较采用方差分析;采用Kaplan-Meier生存曲线,分析3种不同引流管覆盖物(自体巩膜、异体巩膜、生物硬脑膜补片)的手术成功率;采用log—rank法分析手术成功率差异;建立Cox比例风险模型,预测手术失败的危险因素。结果生物硬脑膜补片(MⅡ型)组有6只眼发生结膜后退,致覆盖物暴露;异体和自体巩膜组分别有1只眼和2只眼发生晚期引流盘周纤维组织包裹,致眼压升高;异体巩膜组有1只眼发生引流管暴露。Kaplan-Meier生存曲线分析,显示随访至第12个月时,35例(35只眼)患者中,有25例(25只眼)手术成功,手术总成功率达71.4%;其中异体巩膜组、生物硬脑膜补片组及自体巩膜组手术成功率分别为8/10、3/9及14/16,组间手术成功率差异有统计学意义(P=0.009)。房水引流阀植入术失败的相关危险因素分析,显示生物硬脑膜补片覆盖物是手术失败的危险因素(HR=10.844,P=0.015)。3个组患者术后各随访时间点的平均眼压均较术前明显降低,但组间各检测时间点的平均眼压差异均无统计学意义(F=0.028~1.218,P〉0.05)。结论房水引流阀植入联合自体或异体巩膜覆盖治疗难治性青光眼的疗效相当,手术成功率高。生物硬脑膜补片与结膜组织相容性差,最终导致并发症,致手术成功率低,不适合用于房水引流阀植入术中。
周民稳王伟王世明黄丹平葛坚张秀兰
关键词:青光眼巩膜外科皮瓣
Cod liver oil: a potential protective supplement for human glaucoma被引量:1
2011年
· Glaucoma is one of the leading causes of visual impairment and blindness. Improved knowledge of the pathogenesis of this disease has allowed the exploration of new therapeutic methods. In general, elevated intraocular pressure (IOP), oxidative stress, and vascular insufficiency are accepted as the major risk factors for the progression of glaucoma. Many natural compounds have been found beneficial for glaucoma. Nutritional therapies are now emerging as potentially effective in glaucomatous therapy. One nutritional supplement with potential therapeutic value is cod liver oil, a dietary supplement that contains vitamin A and omega-3 polyunsaturated fatty acids (PUFAs). Vitamin A is important for preserving normal vision and it is a well-known antioxidant that prevents the oxidative damage that contributes to the etiology and progression of glaucoma. Vitamin A is also a crucial factor for maintaining the integrity of conjunctival and corneal ocular surfaces, and preventing the impairment of ocular epithelium caused by topical antiglaucomatous drugs. Omega-3 fatty acids are beneficial for glaucoma patients as they decrease IOP, increase ocular blood flow, and improve optic neuroprotective function. In this article, we propose that cod liver oil, as a combination of vitamin A and omega-3 fatty acids, should be beneficial for the treatment of glaucoma. However, further studies are needed to explore the relationship between cod liver oil and glaucoma. ·
Wen-Bin HuangQian Fanand Xiu-Lan Zhang
关键词:OILGLAUCOMAFATTYACIDSVITAMIN
共1页<1>
聚类工具0